425: Strive CFO Confirms Semler Scientific Merger Plans

Strive, Inc.'s CFO, Ben Pham, confirmed the proposed business combination with Semler Scientific, Inc. via an X.com post on September 22, 2025.

Summary

• Strive, Inc. announced a proposed business combination with Semler Scientific, Inc.
• The announcement was made through a communication posted on X.com by Ben Pham, Strive's Chief Financial Officer, on September 22, 2025.
• The transaction is subject to various conditions, including the timely receipt or satisfaction of closing conditions and approval from Semler Scientific's stockholders.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus for the proposed transaction.
• The combined company is expected to realize strategic and financial benefits, including anticipated cost savings and strategic gains, and a positive impact on future financial performance.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive, as it announces a strategic business combination with anticipated benefits. However, the extensive cautionary statements and detailed list of risks temper the overall positivity, indicating a realistic assessment of potential challenges inherent in such transactions.

Positives

• The proposed business combination is anticipated to yield strategic benefits for the combined company.
• Expected financial benefits include anticipated cost savings and strategic gains.
• The transaction is projected to have a positive impact on the combined company's future financial performance.

Risks

• The merger agreement could be terminated by either Strive or Semler Scientific due to various circumstances.
• The proposed transaction may not close as expected or at all if conditions to closing are not met or satisfied on a timely basis.
• Potential legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks are associated with the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could adversely affect the transaction.
• The integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors or events.
• Management's attention may be diverted from ongoing business operations and opportunities during the transaction process.
• Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction could cause dilution.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships may occur.
• Changes in Strive's or Semler Scientific's share price before closing could impact the transaction.

Future Outlook

The proposed business combination is expected to bring strategic and financial benefits, including cost savings and strategic gains, and is anticipated to positively impact the combined company's future financial performance. The timing of the closing and the ability to successfully integrate the businesses are key forward-looking expectations.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., posted a communication on X.com on September 22, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

This announcement reflects a trend of strategic consolidation within industries, potentially driven by a desire to achieve economies of scale, expand market reach, or integrate new technologies or asset strategies, such as Bitcoin treasury holdings, which introduces a novel element to traditional corporate finance.

Corporate Governance

Legal Proceedings

• The possibility that the outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company could cause actual results to differ materially from anticipated results.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Shareholders of Semler Scientific will be required to vote on the proposed transaction.
• Customers of both Strive and Semler Scientific may have adverse reactions or experience changes to business relationships.
• Employees of both companies may experience changes to their relationships or employment conditions.
• The combined company's future financial performance is expected to be impacted by the strategic and financial benefits of the merger.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

The filing confirms an ongoing merger process, which is generally price-sensitive. However, it is a standard regulatory communication rather than a new development. The extensive list of risks associated with the merger, including integration challenges, potential non-realization of benefits, and dilution, suggests caution. While the strategic intent is positive, the uncertainties warrant a 'hold' until more definitive terms, financial projections, and integration plans are disclosed, allowing for a clearer assessment of the combined entity's value and risk profile.

Keywords

Strive Inc., Semler Scientific Inc., merger, acquisition, business combination, SEC filing, Form 425, Bitcoin treasury, digital assets, corporate governance, financial performance